multiple imputation (mi) with fully conditional specification (fcs) in sas 9.4 Search Results


mda mb  (ATCC)
99
ATCC mda mb
Mda Mb, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/us08067424-1323-380-50?v=ATCC
Average 99 stars, based on 1 article reviews
mda mb - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
elisa il 4 kit  (Multi Sciences (Lianke) Biotech Co Ltd)
94
Multi Sciences (Lianke) Biotech Co Ltd elisa il 4 kit
Elisa Il 4 Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pmc12237309-181-3-17?v=Multi+Sciences+%28Lianke%29+Biotech+Co+Ltd
Average 94 stars, based on 1 article reviews
elisa il 4 kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
nanosight device  (NanoSight ltd)
90
NanoSight ltd nanosight device
Nanosight Device, supplied by NanoSight ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pmc07782545-77-6-6?v=NanoSight+ltd
Average 90 stars, based on 1 article reviews
nanosight device - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nci h226 5 94  (ATCC)
96
ATCC nci h226 5 94
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Nci H226 5 94, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pmc04400819-131-77-58?v=ATCC
Average 96 stars, based on 1 article reviews
nci h226 5 94 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
fbs hcc1937 atcc brca1 q1756fs  (ATCC)
97
ATCC fbs hcc1937 atcc brca1 q1756fs
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Fbs Hcc1937 Atcc Brca1 Q1756fs, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pmc06838110__41467_2019_12836_MOESM1_ESM-17-59-61?v=ATCC
Average 97 stars, based on 1 article reviews
fbs hcc1937 atcc brca1 q1756fs - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
cell culture page 4 19  (ATCC)
97
ATCC cell culture page 4 19
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Cell Culture Page 4 19, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/ppr0198285-60-1-16?v=ATCC
Average 97 stars, based on 1 article reviews
cell culture page 4 19 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
version 13 1  (STATA Corporation)
99
STATA Corporation version 13 1
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Version 13 1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pm28457213-65-14-13?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
version 13 1 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
molt  (ATCC)
93
ATCC molt
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Molt, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/us08067424-1323-28-50?v=ATCC
Average 93 stars, based on 1 article reviews
molt - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
human chondrosarcoma sw 1353  (ATCC)
96
ATCC human chondrosarcoma sw 1353
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Human Chondrosarcoma Sw 1353, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pm38772186-180-38-42?v=ATCC
Average 96 stars, based on 1 article reviews
human chondrosarcoma sw 1353 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
protease inhibitor multi mmp inhibitor batimastat  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology protease inhibitor multi mmp inhibitor batimastat
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Protease Inhibitor Multi Mmp Inhibitor Batimastat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/us10377818-1306-13-21?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
protease inhibitor multi mmp inhibitor batimastat - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
nonsmall cell lung cancer a549 atcc  (ATCC)
92
ATCC nonsmall cell lung cancer a549 atcc
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Nonsmall Cell Lung Cancer A549 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pm33458465-51-83-86?v=ATCC
Average 92 stars, based on 1 article reviews
nonsmall cell lung cancer a549 atcc - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
breast cancer mcf7 94 78 mda mb  (ATCC)
90
ATCC breast cancer mcf7 94 78 mda mb
Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen
Breast Cancer Mcf7 94 78 Mda Mb, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+imputation+%28mi%29+with+fully+conditional+specification+%28fcs%29+in+sas+9%2E4/pmc10940605__41598_2024_56313_MOESM11_ESM-1-154-158?v=ATCC
Average 90 stars, based on 1 article reviews
breast cancer mcf7 94 78 mda mb - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen

Journal: Bioorganic & medicinal chemistry letters

Article Title: Synthesis and in vitro screening of novel N -benzyl aplysinopsin analogs as potential anticancer agents

doi: 10.1016/j.bmcl.2011.01.020

Figure Lengend Snippet: Antitumor activity (GI 50 / μM) a and toxicity (LC 50 / μM) b data of compounds selected for 5 dose studies for the NCI 60-cell lines screen

Article Snippet: The results are presented in . table ft1 table-wrap mode="anchored" t5 caption a7 Panel/cell line Compound 3a Compound 3i GI 50 LC 50 GI 50 LC 50 Leukemia Cancer CCRF-CEM 3.06 >100 >100 >100 HL-60(TB) 2.54 >100 >100 >100 K-562 0.97 >100 77.6 >100 MOLT-4 1.38 >100 >100 >100 RPMI-8226 3.61 >100 >100 >100 Non-Small Cell Lung Cancer A549/ATCC 4.44 >100 0.77 >100 EKVX 4.22 >100 >100 >100 HOP-62 3.58 73.0 >100 >100 HOP-92 na na >100 NCI-H226 5.94 >100 80.7 >100 NCI-H23 4.07 >100 60.1 >100 NCI-H322M 0.72 >100 71.0 >100 NCI-H460 2.91 >100 >100 >100 NCI-H522 na na 11.0 >100 Colon Cancer COLO 205 3.16 >100 >100 >100 HCC-2998 2.43 85.0 >100 >100 HCT-116 1.21 >100 5.41 >100 HCT-15 na na >100 >100 HT29 5.99 >100 20.8 >100 KM12 3.73 >100 7.49 >100 SW-620 2.27 >100 38.3 >100 CNS Cancer SF-268 4.22 >100 32.0 >100 SF-295 3.09 >100 >100 >100 SF-539 2.39 >100 4.40 >100 SNB-19 3.77 >100 >100 >100 SNB-75 4.60 >100 2.47 >100 U-251 2.03 59.1 2.94 >100 Melanoma Cancer LOX IMVI 1.43 >100 2.32 >100 MALME-3M 2.01 >100 23.5 >100 M14 1.43 >100 57.2 >100 MDA-MB-435 2.76 >100 32.4 >100 SK-MEL-2 0.30 30.6 >100 >100 SK-MEL-28 3.79 >100 >100 >100 SK-MEL-5 3.25 >100 >100 >100 UACC-257 4.20 >100 0.013 0.30 UACC62 1.27 51.0 >100 >100 Ovarian Cancer IGR-OV1 0.66 >100 3.02 >100 OVCAR-3 2.05 >100 >100 30.1 OVCAR-4 4.13 >100 2.49 >100 OVCAR-5 5.51 >100 >100 >100 OVCAR-8 3.75 >100 0.019 >100 NCI/ADR-RES >100 >100 >100 >100 SK-OV-3 0.86 79.8 >100 >100 Renal Cancer 786-0 2.36 >100 37.4 >100 A498 0.55 >100 31.5 >100 ACHN 2.08 >100 >100 >100 CAKI-1 2.74 >100 >100 >100 RXF 393 0.58 >100 1.62 >100 SN12C 2.80 >100 >100 >100 TK-10 3.87 >100 5.64 >100 UO-31 2.70 >100 >100 >100 Prostate Cancer PC-3 2.44 >100 23.6 >100 DU-145 na na 5.24 >100 Breast Cancer MCF7 3.55 >100 >100 >100 MDA-MB-231/ATCC 3.32 >100 6.45 >100 HS 578T 0.97 >100 3.67 >100 BT-549 1.24 >100 98.8 >100 T-47D 1.50 >100 >100 >100 MDA-MB-468 4.14 >100 >100 >100 Open in a separate window NA: Not analyzed a GI 50 : 50% Growth inhibition, concentration of drug resulting in a 50% reduction in net protein increase compared with control cells. b LC 50 : Lethal concentration, concentration of drug lethal to 50% of cells.

Techniques: Activity Assay